RAP2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.640800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.222610E-01
Normal-vs-Stage2
6.599800E-01
Normal-vs-Stage3
3.513800E-01
Normal-vs-Stage4
9.331000E-01
Stage1-vs-Stage2
3.162800E-01
Stage1-vs-Stage3
8.970600E-01
Stage1-vs-Stage4
4.985400E-01
Stage2-vs-Stage3
3.389400E-01
Stage2-vs-Stage4
7.388200E-01
Stage3-vs-Stage4
4.863000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.512200E-01
Normal-vs-AfricanAmerican
3.954200E-01
Normal-vs-Asian
7.932600E-01
Caucasian-vs-AfricanAmerican
6.104000E-01
Caucasian-vs-Asian
5.629600E-01
AfricanAmerican-vs-Asian
4.574000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.401000E-01
Normal-vs-Female
6.116200E-01
Male-vs-Female
6.636800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.878800E-01
Normal-vs-Age(41-60Yrs)
8.339000E-01
Normal-vs-Age(61-80Yrs)
4.798600E-01
Normal-vs-Age(81-100Yrs)
4.701400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.639400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.554600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.174600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.508200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.143800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.575200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.361200E-01
Normal-vs-Daily Drinker
2.465800E-01
Normal-vs-Weekly Drinker
7.639200E-01
Normal-vs-Occasional Drinker
8.038200E-01
Normal-vs-Social Drinker
1.699840E-01
Non Drinker-vs-Daily Drinker
3.054600E-01
Non Drinker-vs-Weekly Drinker
7.977400E-01
Non Drinker-vs-Occasional Drinker
6.570200E-01
Non Drinker-vs-Social Drinker
3.503600E-01
Daily Drinker-vs-Weekly Drinker
2.599800E-01
Daily Drinker-vs-Occasional Drinker
1.593010E-01
Daily Drinker-vs-Social Drinker
8.632400E-01
Weekly Drinker-vs-Occasional Drinker
8.970200E-01
Weekly Drinker-vs-Social Drinker
3.470400E-01
Occasional Drinker-vs-Social Drinker
2.246400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.078200E-01
Normal-vs-Grade 2
8.445900E-02
Normal-vs-Grade 3
1.004210E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.01779999999818E-05
Grade 1-vs-Grade 3
2.359500E-04
Grade 1-vs-Grade 4
7.078200E-01
Grade 2-vs-Grade 3
9.735800E-01
Grade 2-vs-Grade 4
8.445900E-02
Grade 3-vs-Grade 4
1.004210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.317000E-01
Normal-vs-NonDiabetic
6.477200E-01
Diabetic-vs-NonDiabetic
2.864600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.952400E-01
Normal-vs-NoPancreatitis
5.425200E-01
Pancreatitis-vs-NoPancreatitis
5.852400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.531000E-01
Normal-vs-N1
6.314400E-01
N0-vs-N1
1.693040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.290800E-01
Normal-vs-TP53-NonMutant
2.627000E-01
TP53-Mutant-vs-TP53-NonMutant
1.5794399999991E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
